The opioid crisis continues to have a profound and devastating impact on the public’s health. The crisis, and the litigation spawned by it, have far reaching impacts for patients and the pharmaceutical industry.  Speakers will highlight the lessons learned from recent cases and settlements, as well as the impact on companies committed to taking an ethical and compliant approach to developing, manufacturing, and marketing of prescription opioid products.